Therapeutic options for intractable hematuria in advanced bladder cancer.

Author: AbtDominik, BywaterMirjam, EngelerDaniel Stephan, SchmidHans-Peter

Paper Details 
Original Abstract of the Article :
Intractable hematuria is a common and severe complication in patients with inoperable bladder carcinoma. The aim was to provide an overview of therapeutic options for such cases, and analyze their effectiveness and risk profile, so a systematic literature search of peer-reviewed papers published up ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/iju.12113

データ提供:米国国立医学図書館(NLM)

Tackling Intractable Hematuria in Advanced Bladder Cancer: A Journey Through Treatment Options

Navigating the treacherous desert of advanced bladder cancer can be a daunting task, especially when dealing with a complication like intractable hematuria, persistent blood in the urine. This study delves into the various treatment options available for this challenging condition. The researchers reviewed the existing literature and categorized the available treatments, highlighting their potential benefits, risks, and limitations.

A Multifaceted Approach to Hematuria

The study provides a comprehensive overview of treatment options for intractable hematuria in patients with inoperable bladder cancer. However, the researchers emphasize the need for further studies to compare the effectiveness of different treatments and identify the optimal approach for individual patients.

Finding the Right Path Through Treatment

The study's findings highlight the complexity of managing intractable hematuria in advanced bladder cancer. It's essential for patients to consult with a healthcare professional to discuss treatment options and make informed decisions based on their specific circumstances and goals.

Dr.Camel's Conclusion

This study offers a valuable guide to navigating the complex landscape of treatment options for intractable hematuria in patients with advanced bladder cancer. It highlights the need for continued research and personalized care to address this challenging complication.

Date :
  1. Date Completed 2014-03-03
  2. Date Revised 2013-07-12
Further Info :

Pubmed ID

23387805

DOI: Digital Object Identifier

10.1111/iju.12113

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.